Cargando…
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines
BACKGROUND: Chemotherapy-induced alopecia (CIA) is a distressing side effect of cancer therapy. The trial aimed to assess feasibility and effectiveness of scalp-cooling system DigniCap® to prevent CIA in primary breast cancer patients receiving an anthracycline containing adjuvant chemotherapy (CT)....
Autores principales: | Munzone, Elisabetta, Bagnardi, Vincenzo, Campennì, Giuseppe, Mazzocco, Ketti, Pagan, Eleonora, Tramacere, Andrea, Masiero, Marianna, Iorfida, Monica, Mazza, Manuelita, Montagna, Emilia, Cancello, Giuseppe, Bianco, Nadia, Palazzo, Antonella, Cardillo, Anna, Dellapasqua, Silvia, Sangalli, Claudia, Pettini, Greta, Pravettoni, Gabriella, Colleoni, Marco, Veronesi, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738323/ https://www.ncbi.nlm.nih.gov/pubmed/31303642 http://dx.doi.org/10.1038/s41416-019-0520-8 |
Ejemplares similares
-
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.”
por: Munzone, Elisabetta, et al.
Publicado: (2019) -
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials
por: Munzone, E., et al.
Publicado: (2021) -
Pegylated Liposomal Doxorubicin (Caelyx(®)) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial
por: Dellapasqua, Silvia, et al.
Publicado: (2021) -
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
por: Montagna, Emilia, et al.
Publicado: (2020) -
Assessing Predictors of Tamoxifen Nonadherence in Patients with Early Breast Cancer
por: Montagna, Emilia, et al.
Publicado: (2021)